Sara Ramella
Overview
Explore the profile of Sara Ramella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
136
Citations
1573
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramella S, Fiore M, DAngelillo R
J Thorac Oncol
. 2025 Mar;
20(3):256-258.
PMID: 40049765
No abstract available.
2.
Borghetti P, Ramella S, Ricardi U
Front Oncol
. 2025 Feb;
14:1541527.
PMID: 39927114
Small cell lung cancer (SCLC) is an aggressive tumor that presents in most cases as a metastatic disease. The prognosis is poor, but the advent of immunotherapy has rekindled hopes...
3.
Fiore M, Petrianni G, DErcole G, Onorati E, Trecca P, Alaimo R, et al.
J Clin Med
. 2025 Jan;
13(24.
PMID: 39768662
Pancreatic cancer, with its poor prognosis, is frequently diagnosed in elderly patients who may be ineligible for surgery or chemoradiation due to age or comorbidities. Stereotactic body radiotherapy (SBRT) offers...
4.
Ramella S, Ippolito E, DAngelillo R
N Engl J Med
. 2024 Dec;
391(24):2385.
PMID: 39693555
No abstract available.
5.
Mariotti S, Minuti G, Landi L, Bria E, Carlucci G, Di Salvatore M, et al.
Heliyon
. 2024 Dec;
10(23):e39324.
PMID: 39687089
Small-Cell Lung Cancer (SCLC) accounts for 15 % of all lung cancer cases. Due to comorbidities and its aggressive behaviour, patients are highly symptomatic even at a non-metastatic stage. Standardizing...
6.
Fiore M, DErcole G, Petrianni G, Trecca P, Ramella S
Pract Radiat Oncol
. 2024 Nov;
14(6):603-604.
PMID: 39487010
No abstract available.
7.
Bertolaccini L, Tralongo A, Del Re M, Facchinetti F, Ferrara R, Franchina T, et al.
Lung Cancer
. 2024 Oct;
197:107990.
PMID: 39461280
While recent randomized controlled trials (RCT) have suggested superior overall survival (OS) outcomes with segmentectomy over lobectomy, questions remain regarding the comparability of these surgical procedures for treating early-stage non-small...
8.
Asmara O, Hardavella G, Ramella S, Petersen R, Tietzova I, Boerma E, et al.
Breathe (Sheff)
. 2024 Oct;
20(3):240047.
PMID: 39360027
Stage III nonsmall cell lung cancer (NSCLC) represents a wide range of tumour (T1 to T4) and nodal (N0 to N3) components, requiring variable management and a multidisciplinary approach. Recent...
9.
Alongi F, Nicosia L, Ricardi U, Scorsetti M, Greto D, Balermpas P, et al.
Radiother Oncol
. 2024 Aug;
199:110466.
PMID: 39094630
Aim: To evaluate acute toxicity at 6 months after stereotactic body radiotherapy (SBRT) in patients with oligometastatic cancer within the OligoCare cohort. Material And Methods: OligoCare is a prospective, registry-based,...
10.
Citarella F, Takada K, Cascetta P, Crucitti P, Petti R, Vincenzi B, et al.
J Transl Med
. 2024 Jul;
22(1):714.
PMID: 39085889
Compared to other malignancies, few studies have investigated the role of family history of cancer (FHC) in patients with lung cancer, yielding largely heterogeneous results. We performed a systematic literature...